Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive (CROSBI ID 241951)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Juričić, Gordana ; Saračević, Andrea ; Milevoj Kopčinović, Lara ; Bakliža, Ana ; Šimundić, Ana- Maria The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive // Clinical biochemistry, 49 (2016), 18; 1402-1405. doi: 10.1016/j.clinbiochem.2016.03.006

Podaci o odgovornosti

Juričić, Gordana ; Saračević, Andrea ; Milevoj Kopčinović, Lara ; Bakliža, Ana ; Šimundić, Ana- Maria

engleski

The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive

Citrate buffer additive has been suggested to be of supreme performance in inhibiting glycolysis. However, there is little evidence in the literature regarding the comparability of glucose concentrations in liquid and lyophilized citrate buffer containing tubes. The aim of this study was to compare glucose concentrations in tubes containing liquid (Glucomedics) and lyophilized citrate buffer (Terumo VENOSAFE™ Glycemia) additive, measured immediately after centrifugation.

Diabetes ; Glucomedics ; Glycolysis inhibitors ; Preanalytical phase ; Venosafe Glycemia

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

49 (18)

2016.

1402-1405

objavljeno

0009-9120

10.1016/j.clinbiochem.2016.03.006

Povezanost rada

Kliničke medicinske znanosti, Farmacija

Poveznice
Indeksiranost